Jackson Creek Investment Advisors LLC
Position in ELAN — Elanco Animal Health Inc
CIK 1831003
CASTLE ROCK, CO
Position in ELAN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$987,845
-$533,145 QoQ
Shares Held
40,140
-36.8% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#225
of 515 holders
Holding Since
Sep 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Jackson Creek Investment Advisors LLC holds $8,805,246 across 7 Drug Manufacturers - Specialty & Generic names. ELAN ranks #5 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
49,619 | $2,035,867 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
10,642 | $1,793,602 | |
| 3 | COLL |
Collegium Pharmaceutical, Inc
|
42,663 | $1,544,400 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
14,298 | $1,183,588 | |
| 5 | ELAN |
Elanco Animal Health Inc
This page
|
40,140 | $987,845 | |
| 6 | ALKS |
Alkermes plc.
|
13,161 | $689,636 | |
| 7 | LQDA |
Liquidia Corp
|
7,153 | $570,308 |
All Filings in ELAN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $987,845 | 40,140 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,520,990 | 63,560 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $1,479,323 | 65,370 | Shares | Sole | 2026-02-09 | |
| 2024-06-30 | $422,207 | 29,259 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $681,578 | 41,866 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $633,428 | 42,512 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $481,566 | 42,844 | Shares | Sole | 2023-11-03 | |
| No filing history on record for this holder in this stock. | ||||||